Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma

Published:2014-05-16 Issue:12 Volume:20 Page:3187-3197
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Al-Ejeh Fares,Pajic Marina,Shi Wei,Kalimutho Murugan,Miranda Mariska,Nagrial Adnan M.,Chou Angela,Biankin Andrew V.,Grimmond Sean M.,Brown Michael P.,Khanna Kum Kum,

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNAs in radiotherapy resistance of cancer; a comprehensive review;Cell Biochemistry and Biophysics;2024-05-28

2. DNA Damage Responses, the Trump Card of Stem Cells in the Survival Game;Advances in Experimental Medicine and Biology;2023

3. Combination radionuclide therapy: A new paradigm;Nuclear Medicine and Biology;2021-07

4. The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition;Cancers;2021-04-19

5. Preventing phenotypic plasticity in cancer to mitigate therapy resistance;Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP